Patent Foramen Ovale (PFO)

Moderate Evidence

Overview

Patent foramen ovale (PFO) is a common structural variation of the heart in which a small flap-like opening between the right and left atria remains incompletely sealed after birth. During fetal development, the foramen ovale serves an important purpose by allowing blood to bypass the lungs, which are not yet in use. In most people, this opening closes naturally in infancy or early childhood. When it remains partially open, it is termed a patent foramen ovale. Population studies suggest PFO is present in roughly one-quarter of adults, making it common and often incidental.

For many individuals, a PFO causes no symptoms and is discovered only during imaging performed for another reason. Its clinical importance arises because, under certain circumstances, the opening may allow a blood clot or other material to pass from the venous circulation to the arterial side of the body, a process often described as paradoxical embolism. This possibility has led to significant interest in PFO as a potential contributor to cryptogenic stroke (stroke without an otherwise clear cause), as well as possible associations with migraine with aura, decompression illness in divers, and low blood oxygen levels in select situations.

Not every PFO is considered medically significant. Conventional evaluation typically considers the size of the shunt, whether an atrial septal aneurysm is also present, the person’s age, history of stroke or transient ischemic attack, and whether other explanations for symptoms exist. In modern cardiology, the main question is usually not whether a PFO exists, but whether it is likely to be causally related to a specific clinical event.

Because PFO is a structural cardiac finding rather than a disease with a single symptom pattern, its relevance varies widely. In many cases, no intervention is pursued. In others—particularly after selected cryptogenic strokes in appropriately evaluated adults—research indicates that PFO closure may reduce recurrent stroke risk compared with medical therapy alone. Even so, decisions are individualized and generally involve careful assessment by cardiology and neurology professionals.

Western Medicine Perspective

Western Medicine Perspective

In conventional medicine, PFO is understood as a persistent communication between the atria caused by incomplete fusion of the septal tissues after birth. It is typically identified through echocardiography, especially transthoracic echocardiography with bubble study, transesophageal echocardiography, or transcranial Doppler used to detect right-to-left shunting. The presence of a PFO alone is not generally viewed as sufficient to explain symptoms; clinicians usually look for a plausible mechanism, such as embolic stroke, and evaluate alternative causes including atrial fibrillation, carotid disease, hypercoagulable states, and small vessel disease.

The strongest evidence in this area relates to secondary prevention after cryptogenic ischemic stroke in carefully selected patients, usually younger adults with embolic-appearing stroke and no better identified cause. Multiple randomized trials have found that transcatheter PFO closure can reduce recurrent stroke risk in selected groups when compared with antiplatelet therapy alone, though it may also increase the risk of atrial fibrillation, particularly around the time of the procedure. As a result, guideline-based care often emphasizes patient selection rather than routine closure for all PFOs.

PFO has also been studied in connection with migraine, especially migraine with aura, but evidence has been less consistent. Some studies suggest a relationship, yet routine PFO closure solely for migraine prevention has not been established as standard care. Similarly, associations with decompression illness, platypnea-orthodeoxia syndrome, and systemic embolism are recognized, but management depends heavily on the full clinical context. From a conventional standpoint, PFO is therefore approached as a risk modifier or contributing anatomic factor, not automatically as a pathologic condition requiring treatment.

Eastern & Traditional Perspective

Eastern and Traditional Medicine Perspective

In Traditional Chinese Medicine (TCM) and related East Asian frameworks, a condition such as PFO is not historically described as a discrete anatomical diagnosis, since classical systems were developed without modern cardiac imaging. Instead, symptoms or patterns that may accompany cardiovascular vulnerability—such as palpitations, fatigue, shortness of breath, dizziness, chest discomfort, or post-stroke sequelae—might be interpreted through broader pattern categories involving the Heart, Lung, Blood, and Qi systems. Depending on the presentation, practitioners may discuss patterns such as Heart Qi deficiency, Blood stasis, or disharmony affecting circulation and consciousness.

In Ayurveda, there is likewise no direct classical equivalent to PFO as a congenital interatrial opening. Relevant interpretations may be framed in terms of hridroga (heart-related disorders), circulatory imbalance, or disturbances in Vata, Pitta, or Kapha depending on associated symptoms and constitutional factors. Traditional systems often emphasize the person’s overall vitality, circulation, recovery after neurologic events, stress regulation, digestion, sleep, and functional resilience rather than focusing only on a structural cardiac finding.

Naturopathic and integrative traditions may view PFO within a broader context of cardiovascular and neurologic risk assessment, supporting general health measures while recognizing that a structural heart communication is fundamentally a matter for modern diagnostic cardiology. Research on acupuncture, mind-body practices, or traditional herbal systems has largely focused on symptom support, stroke rehabilitation, or migraine management rather than on altering the PFO itself. Accordingly, traditional approaches are best understood as complementary frameworks for symptom patterns and whole-person care, not as replacements for cardiology evaluation when stroke, embolic risk, or unexplained hypoxemia is a concern.

Across traditional systems, the key limitation is that PFO is primarily an anatomical diagnosis confirmed by imaging, so the evidence base for eastern approaches is indirect. Consultation with qualified healthcare professionals is important when integrating traditional care with conventional evaluation, especially in anyone with neurologic symptoms, prior stroke, or suspected cardiac shunting.

Related Topics

Migraine

Migraine — a condition in the health ontology.

How They Relate

Condition / Condition

Migraine & Patent Foramen Ovale (PFO)

Migraine is a neurologic disorder marked by recurrent headaches and sensory symptoms. About 12–15% of people experience migraine; roughly one-third have migraine with aura (visual or sensory distur...

Evidence & Sources

Moderate Evidence

Promising research with growing clinical support from multiple studies

  1. American Heart Association/American Stroke Association Guidelines
  2. Society for Cardiovascular Angiography and Interventions (SCAI) Guidelines
  3. New England Journal of Medicine
  4. Circulation
  5. Journal of the American College of Cardiology
  6. BMJ
  7. National Institute of Neurological Disorders and Stroke (NINDS)
  8. National Center for Complementary and Integrative Health (NCCIH)

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.